TOP
Needle-Trap is delivered on rolls and processed without additional process steps. That reduces complexity and accelerates implementation.

Together for Safe Syringes

SCHREINER MEDIPHARM

Together for Safe Syringes

Fewer interfaces, shorter processes, greater efficiency. Schreiner MediPharm and Morpho, a contract manufacturer for the pharmaceutical industry, are combining their expertise to create an integrated solution for processing the Needle-Trap needle protection system on prefilled syringes. This collaboration offers pharmaceutical manufacturers numerous advantages—from easy process integration to streamlined workflows.

Concentrated Competence

Schreiner MediPharm’s Needle-Trap needle protection system has proven itself billions of times since 2009, for instance in use with heparins, biosimilars, biologics, and vaccines. The label with an integrated needle trap increases the safety of handling prefilled syringes and prevents needlestick injuries after an injection. The partnership between Schreiner MediPharm and Morpho combines the expertise of two specialists. While Schreiner MediPharm offers an established needle protection system, Morpho contributes its comprehensive expertise as a CDMO (Contract Development and Manufacturing Organization). This provides pharmaceutical manufacturers with an integrated solution in which product and processing are optimally aligned.

Needle-Trap is delivered on rolls and processed without additional process steps. That reduces complexity and accelerates implementation.
Needle-Trap is delivered on rolls and processed without additional process steps. That reduces complexity and accelerates implementation.
The coordinated production processes at Schreiner MediPharm and Morpho enable integration of Needle-Trap into existing packaging lines in a reliable and efficient process.
The coordinated production processes at Schreiner MediPharm and Morpho enable integration of Needle-Trap into existing packaging lines in a reliable and efficient process.

Seamless Integration

Needle-Trap is delivered on rolls and can be applied on Morpho’s specially adapted labeling systems without additional process steps. The technical coordination between the two partners takes place in the background. As a result, customers benefit from a true one-stop shop, reducing communication effort and interfaces, shortening implementation times and completing projects more quickly. At the same time, Needle-Trap can be flexibly adapted to different syringe formats—from standard sizes to large-volume syringes for biologics and biosimilars.

Safety, Economy, and Sustainability

In addition, Needle-Trap can be equipped with a seal function for first-opening indication, enabling the elimination of the need for the standard blister pack. Needle-Trap’s compact design reduces material use, packaging volume, transportation and warehousing requirements. All of this contributes to lower CO₂ emissions and reduced costs. For pharmaceutical manufacturers, the partnership means higher process reliability and a solution that’s fit for the future and has proven itself worldwide in numerous commercial applications.

Morpho is a technology-driven full-service CDMO (Contract Development and Manufacturing Organization for the pharma industry) and part of the Alfasigma Group. The company has comprehensive expertise in sterile fill-finish production, GMP manufacturing, and packaging of prefilled syringes and other primary containers. Combining deep pharmaceutical expertise with a partnership-led approach, Morpho works with customers and partners to reduce complexity and help shape more efficient, reliable solutions.